| JXHS2100009 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-01-23 | | | In Review | 2022-01-26 | view |
| CYHS1900480 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2019-07-22 | 山东鲁抗医药股份有限公司 | Shandong Lukang Pharmaceutical Co Ltd | Certificate Issued | 2021-11-02 | view |
| CYHS2000307 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2020-05-06 | 北京福元医药股份有限公司 | Beijing Foyou Pharma Co Ltd | Certificate Issued | 2021-11-02 | view |
| CYHS1900479 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2019-07-22 | 山东鲁抗医药股份有限公司 | Shandong Lukang Pharmaceutical Co Ltd | Certificate Issued | 2021-11-02 | view |
| CYHS2100305 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2021-04-01 | 成都倍特药业股份有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | In Review | 2021-03-31 | view |
| CYHS2100306 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2021-04-01 | 成都倍特药业股份有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | In Review | 2021-03-31 | view |
| JXHS2000027 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-03-18 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2021-02-03 | view |
| JXHS2000028 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-03-18 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2021-02-03 | view |
| JYHB2100083 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2021-01-21 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Filed | 2021-01-28 | view |
| JYHB2100082 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2021-01-21 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Filed | 2021-01-28 | view |
| CYHS2100116 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2021-01-27 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | In Review | 2021-01-26 | view |
| CYHS2100117 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2021-01-27 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | In Review | 2021-01-26 | view |
| JXHS2100010 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-01-23 | | | In Review | 2021-01-22 | view |
| JXHB2100010 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2021-01-22 | | | In Review | 2021-01-21 | view |
| JXHB2100011 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2021-01-22 | | | In Review | 2021-01-21 | view |
| JYHB2001526 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2020-08-20 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-10-23 | view |
| JYHB2001525 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2020-08-20 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-10-23 | view |
| JYHB2001771 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2020-09-14 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Filed | 2020-09-30 | view |
| JYHB2001770 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2020-09-14 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Filed | 2020-09-30 | view |
| JYHB2001112 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2020-06-30 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2020-07-01 | view |
